Odyssey Health (ODYY) Amortizatization of Intangibles (2019 - 2026)
Odyssey Health's (ODYY) quarterly Amortizatization of Intangibles came in at $392672.0 in Q2 2026, up 3275.5% year-on-year from $11633.0 in Q2 2025, and up 35.78% quarter-over-quarter from $289190.0 in Q1 2026.
Odyssey Health (ODYY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Odyssey Health's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $392672.0 for Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 3275.5% year-over-year to $392672.0 in Q2 2026; TTM through Apr 2026 was $728964.0, a 714.91% increase from a year earlier, with the FY2025 full-year figure at $50965.0, down 84.59% from the prior year.
- Amortizatization of Intangibles rose to $392672.0 in Q2 2026 per ODYY's latest filing, from $289190.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $392672.0 in Q2 2026 and bottomed at -$23450.0 in Q3 2022.
- The 5-year median for Amortizatization of Intangibles is $77825.0 (2022), against an average of $111167.2.
- Across the five-year window, Amortizatization of Intangibles plunged 125.04% in 2022 and surged 3275.5% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $68054.0 in 2022, then soared by 93.47% to $131662.0 in 2023, then slumped by 84.96% to $19801.0 in 2024, then surged by 99.99% to $39601.0 in 2025, then soared by 891.57% to $392672.0 in 2026.
- Per Business Quant, the three latest ODYY Amortizatization of Intangibles figures stand at $392672.0 (Q2 2026), $289190.0 (Q1 2026), and $39601.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 392,672.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 392,672.00 |
| Apr 30, 2026 | 392,672.00 |
| Jan 31, 2026 | 289,190.00 |
| Jan 31, 2026 | 289,190.00 |
| Oct 31, 2025 | 39,601.00 |
| Oct 31, 2025 | 39,601.00 |
| Jul 31, 2025 | 7,501.00 |
| Jul 31, 2025 | 7,501.00 |
| Apr 30, 2025 | 11,633.00 |
| Apr 30, 2025 | 11,633.00 |
| Jan 31, 2025 | 12,030.00 |
| Jan 31, 2025 | 12,030.00 |
| Oct 31, 2024 | 19,801.00 |
| Oct 31, 2024 | 19,801.00 |
| Jul 31, 2024 | 45,989.00 |
| Jul 31, 2024 | 45,989.00 |
| Apr 30, 2024 | 65,407.00 |
| Apr 30, 2024 | 65,407.00 |
| Jan 31, 2024 | 87,596.00 |
| Jan 31, 2024 | 87,596.00 |